Abstract
Handling missing values in multi-omics datasets is essential for a broad range of analyses. While several benchmarks for multi-omics data imputation methods have recommended certain approaches for practical applications, these recommendations are not widely adopted in real-world data analyses. Consequently, the practical reliability of these methods remains unclear. Furthermore, no existing benchmark has assessed the impact of missing data and imputation on molecular quantitative trait loci (xQTL) discoveries. To establish the best practice for xQTL analysis amidst missing values in multi-omics data, we have thoroughly benchmarked 16 imputation methods. This includes methods previously recommended and in use in the field, as well as two new approaches we developed by extending existing methods. Our analysis indicates that no established method consistently excels across all benchmarks; some can even result in significant false positives in xQTL analysis. However, our extension to a recent Bayesian matrix factorization method, FLASH, exhibits superior performance in multi-omics data imputation across various scenarios. Notably, it is both powerful and well-calibrated for xQTL discovery compared to all the other methods. To support researchers in practically implementing our approach, we have integrated our extension to FLASH into the R package flashier, accessible at https://github.com/willwerscheid/flashier. Additionally, we provide a bioinformatics pipeline that implements FLASH and other methods compatible with xQTL discovery workflows based on tensorQTL, available at https://cumc.github.io/xqtl-pipeline/code/data_preprocessing/phenotype/phenotype_imputation.html.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GW was supported by NIH grant AG076901, and JT was supported by NIH grants AG078733 and AG083941.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors